Photo: File/RHC
MOSCOW, September 12 (RHC) Scientists from the Research Institute of Microbiology and Parasitology in the Russian city of Rostov have developed a vaccine against rotavirus, the National Service for Consumer Protection, Rospotrebnadzor, announced on Monday.
Clinical trials of the drug are currently in the final stages and its production is expected to start in 2023, Rospotrebnadzor reported Monday on his VKontakte social network page.
The company explained that rotavirus is the causative agent of about 40 percent of all acute intestinal infections, which can be transmitted at any age.
However, the disease most commonly affects children between the ages of one and a half and two years old, and the virus is usually transmitted through dirty hands, contaminated food or objects. (font: Latin Press).